Simplify Logo

Full-Time

Senior Director

Pharmacology & DMPK

Confirmed live in the last 24 hours

Prime Medicine

Prime Medicine

201-500 employees

Develops next-generation gene editing technology

Hardware
Biotechnology
Healthcare

Expert

Cambridge, MA, USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • Advanced degree such as M.S. or Ph.D. in biological sciences
  • 10+ years of relevant experience in toxicology, pharmacology, or related discipline
  • Experience designing PK/PD studies including large animal studies
  • Experience building and managing collaborations with CROs, consultants, pharmaceutical partners, and other organizations
  • Ability to manage multiple therapeutic programs in parallel
  • Strong appreciation for research with a focus on product development and preclinical studies
  • Proven track record of strategic thinking and tactical implementation
  • Comfortable in an entrepreneurial and fast-paced environment
Responsibilities
  • Lead Pharmacology, BA, and DMPK groups
  • Design, execute, analyze, and interpret pharmacology, PK/PD, mechanistic, and safety studies
  • Maintain an effective network of outside partners and collaborators
  • Provide support to Tech Ops for real-time issues with drug substance/drug product
  • Ensure high-quality review of study documents and represent Pharmacology during interactions with Regulatory Agencies
  • Foster transparency of progress against department goals and manage conflicting priorities
  • Provide guidance on potential business development opportunities

Prime Medicine, Inc. is a pioneering force in the field of genetic disease treatment through its development of Prime Editing technology. This cutting-edge tool aims to correct faulty DNA sequences by replacing them directly in the genome, targeting about 90% of known genetic mutations associated with diseases. Working at this company provides an opportunity to be at the forefront of genetic research, contributing to potentially transformative treatments that could have far-reaching implications for health and medicine.

Company Stage

N/A

Total Funding

$596M

Headquarters

Cambridge, Massachusetts

Founded

2019

Growth & Insights
Headcount

6 month growth

5%

1 year growth

4%

2 year growth

65%